戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 1373560作成日:2026年10月27日

Sodium triacetoxyborohydride → 7-{4-[4-(5-Chloro-2-isopropoxy-phenyl)-piperazin-1-yl]-butoxy}-1H-[1,8]naphthyridin-2-one

https://huagongshe.com/reaction/1373560

反応式

関与物質

役割名称HCID仕込み量
反応物Sodium triacetoxyborohydrideHCID 5049666—
反応物1-(5-Chloro-2-isopropoxy-phenyl)-piperazineHCID 21073166—
反応物4-(7-Oxo-7,8-dihydro-1,8-naphthyridin-2-yloxy)butanalHCID 21073380—
溶媒1,1-DichloroethaneHCID 6365—
溶媒Ethyl AcetateHCID 8857—
生成物7-{4-[4-(5-Chloro-2-isopropoxy-phenyl)-piperazin-1-yl]-butoxy}-1H-[1,8]naphthyridin-2-oneHCID 2107371039.3%

反応手順

To a suspension of 4-(7-oxo-7,8-dihydro-[1,8]naphthyridin-2-yloxy)-butyraldehyde (0.206 g, 0.887 mmol, 1 eq) and 1-(5-chloro-2-isopropoxy-phenyl)-piperazine (0.328 g, 0.977 mmol, 1.1 eq) in dichloroethane (5 mL) was added NaBH(OAc)3 (0.535 g, 2.524 mmol, 2.84 eq). The slurry was allowed to stir overnight at room temperature (18 h). Analysis by HPLC showed reaction mostly complete. The mixture was diluted with Ethyl Acetate and quenched with saturated NaHCO3. The organic phase was washed with brine, dried over Na2SO4, filtered and evaporated in vacuo. Purification by silica gel chromatography (2% MeOH/CH2Cl2) followed by formation of the HCl salt using 1N HCl in ether provided the title compound (0.164 g, 39%). MS: APCI: M+1: 471.2 (Exact Mass: 470.21).

情報源と証拠

DOI10.6084/m9.figshare.5104873.v1
特許番号US07160888B2
出典データセットuspto-grants-2007_01
ORD IDord-f603048e6346468d8f33df7451b7959b
出典メモuspto-grants-2007_01